Alume Biosciences, Inc.

10/31/2023

Thank you to Alume Bioscience and Dr. Quyen Nguyen for helping us recognize Roger Tsien as an official Inductee of the National Inventors Hall of Fame®!

A biochemist, Tsien invented green fluorescent protein (GFP) variants, which would go on to be used in biology, chemistry, genetics and medical labs worldwide, allowing researchers to investigate the inner workings of cells or whole animals and to watch molecules interact in real time.

Learn more: https://www.invent.org/inductees/roger-tsien

01/10/2023

Alume never fails to impress! The news this morning was nothing short of amazing!

/PRNewswire/ -- Alume Biosciences, Inc. has secured $13 million in Series B financing to advance its lead candidate, Bevonescein (ALM-488), in Phase 3 clinical...

09/09/2022

Alume Biosciences, Inc. leading the way! This press release illustrates the company's great success navigating the difficult climate a small business faces. Congratulations to the Alume team!

/PRNewswire/ -- Alume Biosciences, Inc, a leader in the field of nerve-targeted diagnostics and therapeutics, announced today that it has been awarded a $3.4M...

08/27/2022

https://www.prnewswire.com/news-releases/alume-biosciences-announces-first-patient-dosed-with-alm-488-in-phase-3-pivotal-study-in-patients-undergoing-head-and-neck-surgery-301610509.html

/PRNewswire/ -- Alume Biosciences, Inc, a leader in the field of nerve-targeted diagnostics and therapeutics, today announced that the first patient has been...

07/28/2022

We are right there with you. Today, July 27th, we honor and support those whose lives have been affected by head and neck cancers. More than ever we are fighting the good fight and we continue to keep patients at the heart of everything we do.

06/27/2022

Employee Spotlight!

Our very own Kim Potter has been with Alume through Phase 1/2 and now into Phase 3 and has recently secured the illustrious title of Manager of Clinical Operations. We are so proud to have Kim on our team and look forward to Alume’s continued growth!

06/19/2022

The Glow is Real.

Imagine yourself watching a beautiful sunset. The sun fades over the horizon into dusk and soon the sky turns black and blends into colors of darkness with the Earth; the perfect illustration of the stark difference between the glow letting you know where you are and the darkness that absorbs all recognition.

The great thing about Alume is that we know the Glow!

05/23/2022

This day is near and dear to our hearts since we are so deeply involved in the clinical trial process.

This year we have the most exciting announcement! We have initiated our pivotal Phase 3 trial!

Find us on www.clinicaltrials.gov for more information and to see if you can participate in this novel research!

04/27/2022

"Middle Market Growth’s 2022 Business Development Report features a list of 'Corporate Development Professionals to Watch.'"

This list names one of our own as leading the way in the field of business development! Congratulations, Robin Sitver!

ROBIN SITVER | Alume Biosciences
Vice President, Corporate Development
Short Hills, NJ

Corporate development professionals to watch from Middle Market Growth's Business Development special report

01/31/2022

Inventor and Co-founder of Alume, Dr. Roger Tsien, won the Nobel Prize for the discovery and development of the green fluorescent protein, GFP! Mentioned here on the IG page for the Aquarium of the Pacific in Long Beach, CA and quite visible in their beautiful umbrella jellies!